Skip to main content
Premium Trial:

Request an Annual Quote

Novartis Crop Protection And Acacia Strike Deal

Premium

RICHMOND, Calif.--Acacia Biosciences here and Novartis Crop Protection announced the signing of a profiling agreement to utilize Acacia's patented Genome Reporter Matrix to aid in the selection and optimization of lead compounds for crop-protection products. Under the agreement, Acacia will provide chemical and biological profiles on a class of Novartis's compounds for an undisclosed fee.

The patented technology incorporates a microarray that measures changes in gene expression with a comprehensive database of expression profiles and a set of software tools that facilitate the comparison of profiles and the discovery of new genes and targets. Acacia said the first generation of this technology is based on the fully sequenced yeast genome.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.